Welcome to our dedicated page for Carerx Corporation news (Ticker: CHHHF), a resource for investors and traders seeking the latest updates and insights on Carerx Corporation stock.
The news page for CareRx Corp (CHHHF) aggregates public updates related to CareRx Corporation, which is described as Canada’s leading provider of pharmacy services to seniors living and other congregate care communities. Readers can use this page to follow how the company reports on its operations, financial performance and capital allocation decisions.
CareRx regularly issues news releases covering its quarterly financial results, including revenue, net income or loss and non-IFRS measures such as EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBITDA per share. These updates often include commentary from management on operational discipline, cost efficiencies, growth phases and the impact of factors such as changes in the mix of branded and generic pharmaceuticals dispensed.
News items also describe CareRx’s activities in its core pharmacy services business, such as the addition of new beds served, the number of residents and communities under service, and developments like the opening and consolidation of pharmacy locations. The company highlights its national network of pharmacy fulfillment centers, its use of technology for multi-dose compliance packaging and its collaboration with home operator partners to support resident health, staff education and medication system quality.
Another recurring theme in CareRx news is investor-focused communication, including announcements of conference calls and webcasts to discuss quarterly and annual results. The company provides dial-in details, webcast links and information on slide presentations and archives. In addition, CareRx has announced the initiation of a quarterly dividend and subsequent dividend declarations, explaining how these fit into its capital allocation approach.
By reviewing the news feed, investors and observers can see how CareRx presents its financial trends, operational initiatives and strategic decisions over time, based solely on the company’s own public disclosures.
CareRx (TSX: CRRX / OTC: CHHHF) announced a CAD$0.02 per common share dividend, declared by the board on December 15, 2025. The dividend is payable on January 21, 2026 to holders of record at the close of business on December 23, 2025. The distribution is designated an eligible dividend for Canadian income tax purposes. The release notes that dividends to non-residents are subject to withholding tax (which may be reduced by treaty) and that U.S. taxation is governed by the Internal Revenue Code. Shareholders are advised to consult a tax advisor for personal tax consequences.
CareRx (CHHHF) will host a conference call to discuss its third quarter 2025 financial results on Tuesday, November 4, 2025 at 8:30 a.m. ET. The company expects to report results for the period ended September 30, 2025 after market close on Monday, November 3, 2025.
Telephone dial-in access: 647-849-3320 or 1-833-752-4643 (connect ~15 minutes early). A live webcast and slide presentation will be available on the Investors > Events and Presentations page at https://carerx.ca/presentations/. The webcast and slides will be archived for 90 days.
CareRx Corporation (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living communities, has announced the initiation of a quarterly dividend program. The company's Board of Directors has declared a dividend of $0.02 per Common Share, payable on October 15, 2025, to shareholders of record as of September 23, 2025.
According to CEO Puneet Khanna, this initiative reflects the company's strong cash generation capabilities and disciplined capital allocation strategy. CareRx remains committed to investing in both organic and inorganic growth initiatives while maintaining financial flexibility.
CareRx Corporation (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living communities, reported Q2 2025 financial results. Revenue reached $91.4 million, up from Q1 2025's $89.6 million but slightly down from Q2 2024's $92.0 million. The company achieved net income of $0.6 million, improving from $0.2 million in Q1 2025 and reversing a $1.4 million loss from Q2 2024.
Notably, Adjusted EBITDA grew to $8.0 million (8.8% margin), showing improvement from both Q1 2025 ($7.8 million) and Q2 2024 ($7.5 million). The company's bed count reached 91,062, marking the start of an expected growth period. Additionally, the Ontario Ministry of Health paused previously scheduled reductions in long-term care pharmacy funding fees, which would have decreased from $1,500 to $1,200 per bed annually.
CareRx Corporation (TSX: CRRX) has scheduled its second quarter 2025 financial results conference call for Thursday, July 31, 2025, at 8:30 a.m. ET. The company will release its Q2 2025 financial results for the period ended June 30, 2025, after market close on Wednesday, July 30, 2025.
Participants can join via telephone by dialing 647-849-3320 or 1-833-752-4643, or through a live webcast available on the company's investor relations website. The webcast presentation will be archived for 90 days on CareRx's website.
CareRx (TSX: CRRX) has announced it will host a conference call with slide presentation to discuss its fourth quarter 2024 financial results on Wednesday, March 5, 2025, at 8:30 a.m. ET. The company plans to release its Q4 2024 financial results via news release around 7:00 a.m. ET on the same day.
Participants can join through two methods:
- Telephone dial-in: 647-484-8814 or 1-844-763-8274 (connect 15 minutes early)
- Live webcast: Available on the Events and Presentations page of CareRx's Investors section website
FAQ
What is the current stock price of Carerx Corporation (CHHHF)?
What is the market cap of Carerx Corporation (CHHHF)?
